Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition
Abstract Background During cancer progression, epithelial cancer cells can be reprogrammed into mesenchymal-like cells with increased migratory potential through the process of epithelial-mesenchymal transition (EMT), representing an essential step of tumor progression towards metastatic state. AGR2...
Main Authors: | Lucia Sommerova, Eva Ondrouskova, Borivoj Vojtesek, Roman Hrstka |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-017-3537-5 |
Similar Items
-
ZEB1/miR-200c/AGR2: A New Regulatory Loop Modulating the Epithelial-Mesenchymal Transition in Lung Adenocarcinomas
by: Lucia Sommerova, et al.
Published: (2020-06-01) -
Identification of AGR2 Gene-Specific Expression Patterns Associated with Epithelial-Mesenchymal Transition
by: Andrea Martisova, et al.
Published: (2022-09-01) -
The potential of Olea europaea extracts to prevent TGFβ1-induced epithelial to mesenchymal transition in human nasal respiratory epithelial cells
by: Rabiatul Adawiyah Razali, et al.
Published: (2018-06-01) -
A Hybrid Epithelial to Mesenchymal Transition in Ex Vivo Cutaneous Squamous Cell Carcinoma Tissues
by: Christopher S. Pulford, et al.
Published: (2022-08-01) -
TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration
by: Wardhani BWK, et al.
Published: (2021-09-01)